≡ Risteys
R8

Documentation Changelog GitHub Contact & Feedback

Follow-up examination after treatment for malignant neoplasms

MESH PheWeb

Z21_FOLLOW__EXAM_TREAT_MALIG_NEOPLASMS

No definition available.

Endpoint definition

↥
FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Hospital Discharge: ICD-10 Z08
Cause of death: ICD-10 Z08

3076

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10 ; C.O.D: 10

3076

diagram downward connector

Check minimum number of events None

3076

diagram downward connector

Include endpoints None

3076

diagram downward connector
Z21_FOLLOW__EXAM_TREAT_MALIG_NEOPLASMS

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF4
Parent code in ICD-10 Z[0-1]

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 3076 1724 1352
Unadjusted prevalence (%) 0.86 0.87 0.86
Mean age at first event (years) 63.94 60.18 68.75

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.04 2.28 [1.15, 4.52] 1.8e-2 585
15 years 0.01 1.24 [0.79, 1.96] 3.5e-1 230
5 years 0.00 3.43 [2.52, 4.65] 2.9e-15 214
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: Z21_FOLLOW__EXAM_TREAT_MALIG_NEOPLASMS – Follow-up examination after treatment for malignant neoplasms
GWS hits:

Survival analyses between endpoints

↥

Plot

before Follow-up examination after treatment for malignant neoplasms
after Follow-up examination after treatment for malignant neoplasms

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Follow-up examination after treatment for malignant neoplasms

↥